Farmer J B, Richards I M, Sheard P, Woods A M
Br J Pharmacol. 1975 Sep;55(1):57-64. doi: 10.1111/j.1476-5381.1975.tb07610.x.
Passive lung anaphylaxis (PLA) was investigated in rats sensitized by the intravenous injection of high titre reaginic antiserum prepared in rats. 2 The effect of various pharmacological antagonists on anaphylactic bronchoconstriction in vivo were examined. An antihistamine (mepyramine), a kallikrein inactivator (aprotinin) or a prostaglandin synthesis inhibitor (aspirin) did not inhibit PLA, whereas an anti-5-hydroxytryptamine agent (methysergide) and an anti-slow reacting substance-A agent (FPL 55712) significantly reduced the response. 3 Isolated perfused lungs taken from sensitized rats released, on challenge with the sensitizing antigen, histamine, 5-hydroxytryptamine, slow reacting substance of anaphylaxis (SRS-A) and prostaglandins, but no rabbit aorta contracting substance (RCS). 4 Disodium cromoglycate inhibited both anaphylactic bronchoconstriction in vivo and the anaphylactic release of mediators in vitro. Inhibition in vivo was dose-related. 5 Mediators from the intestine, the primary shock organ of anaphylaxis in the rat, did not contribute to the lung response. 6 Vagal reflex pathways were found not to be important in PLA in vivo. 7 The relationship between the mediators released following antigen challenge of passively sensitized rat lung in vitro and passive lung anaphylaxis in vivo is discussed.
在通过静脉注射在大鼠中制备的高滴度反应素抗血清致敏的大鼠中研究了被动性肺过敏反应(PLA)。2 检测了各种药理拮抗剂对体内过敏性支气管收缩的影响。一种抗组胺药(美吡拉敏)、一种激肽释放酶灭活剂(抑肽酶)或一种前列腺素合成抑制剂(阿司匹林)均未抑制PLA,而一种抗5-羟色胺剂(甲基麦角新碱)和一种抗慢反应物质A剂(FPL 55712)显著降低了反应。3 从致敏大鼠获取的离体灌注肺在用致敏抗原激发时释放组胺、5-羟色胺、过敏反应慢反应物质(SRS-A)和前列腺素,但未释放兔主动脉收缩物质(RCS)。4 色甘酸钠抑制体内过敏性支气管收缩和体外介质的过敏性释放。体内抑制作用与剂量相关。5 来自肠道(大鼠过敏反应的主要休克器官)的介质对肺反应无作用。6 发现迷走神经反射途径在体内PLA中不重要。7 讨论了体外被动致敏大鼠肺在抗原激发后释放的介质与体内被动性肺过敏反应之间的关系。